Is number of sentinel nodes enougth after neoadjuvant chemotherapy?

Bibliographic Details
Main Authors:	S. Aragón, R. Oliver, M.J. Tabuenca, M. López, E. Ciruelos
Format:	Article
Language:	English
Published:	Elsevier 2021-04-01
Series:	Breast
Online Access:	http://www.sciencedirect.com/science/article/pii/S0960977621002307

Sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer
by: Khadidja Brahmi, et al.
Published: (2017-06-01)

Omitting axillary lymph node dissection in breast cancer patients with metastatic sentinel node after neoadjuvant chemotherapy
by: B. Kuru, et al.
Published: (2021-04-01)

Our house believes that: The clipped lymph node is the true sentinel node after neoadjuvant chemotherapy in N+ patients
by: Benigno Acea-Nebril, et al.
Published: (2023-12-01)

Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer with axillary node metastasis: A survey of clinical practice
by: Sae Byul Lee, et al.
Published: (2019-01-01)

Role of SPECT/CT in detection of the marked metastatic lymph node and the sentinel node, after neoadjuvant chemotherapy in patients with breast cancer
by: E. Dilege, et al.
Published: (2021-04-01)

Sentinel Node Biopsy after Neoadjuvant Chemotherapy for Breast Cancer: Preliminary Experience with Clinically Node Negative Patients after Systemic Treatment
by: Alejandro Martin Sanchez, et al.
Published: (2021-03-01)

Sentinel node biopsy alone for breast cancer patients with residual nodal disease after neoadjuvant chemotherapy
by: Jung Whan Chun, et al.
Published: (2021-04-01)

Superparamagnetic Iron Oxide for Identifying Sentinel Lymph Node in Breast Cancer after Neoadjuvant Chemotherapy: Feasibility Study
by: Andrzej Kurylcio, et al.
Published: (2021-07-01)

Feasibility and accuracy of sentinel lymph node biopsy in clinically node-positive breast cancer after neoadjuvant chemotherapy: a meta-analysis.
by: Jian-Fei Fu, et al.
Published: (2014-01-01)

P116 Axillary residual disease in patients with positive sentinel node after neoadjuvant treatment according to tumor subtype
by: L. López-Marín, et al.
Published: (2023-03-01)

Non-sentinel node metastasis prediction during surgery in breast cancer patients with one to three positive sentinel node(s) following neoadjuvant chemotherapy
by: Jung Whan Chun, et al.
Published: (2023-03-01)

P117 Axillary residual disease after neoadjuvant treatment according to disease burden in the sentinel lymph node biopsy
by: L. López-Marín, et al.
Published: (2023-03-01)

Sentinel Lymph Node Biopsy Following Neoadjuvant Chemotherapy: Review of the Literature and Recommendations for Use in Patient Management
by: Yan Xing, et al.
Published: (2004-10-01)

Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with T2 to T4, N0 and N1 breast cancer
by: Andreis, D, et al.
Published: (2016)

Sentinel lymph node biopsy and neoadjuvant chemotherapy in the management of early breast cancer: Safety considerations and timing
by: Jenny Edge, et al.
Published: (2017-06-01)

Regional Recurrence Rates With or Without Complete Axillary Dissection for Breast Cancer Patients with Node-Positive Disease on Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy
by: Diane C. Ling, MD, et al.
Published: (2020-03-01)

The Feasibility and Accuracy of Sentinel Lymph Node Biopsy in Initially Clinically Node-Negative Breast Cancer after Neoadjuvant Chemotherapy: A Systematic Review and Meta-Analysis.
by: Chong Geng, et al.
Published: (2016-01-01)

Performance and oncologic safety of sentinel lymph node biopsy after neoadjuvant chemotherapy: Results from a tertiary care center in Lebanon
by: Mariam Zahwe, et al.
Published: (2024-01-01)

Extended Sentinel Node Biopsy in Breast Cancer Patients who Achieve Complete Nodal Response with Neoadjuvant Chemotherapy
by: Alfredo Carlos Simões Dornellas de Barros, et al.
Published: (2020-04-01)

DOES THE NEOADJUVANT CHEMOTHERAPY REDUCE THE NUMBER OF AXILLARY LYMPH NODES REMOVED IN PATIENTS WITH BREAST CANCER?
by: Kaptan Gülben, et al.
Published: (2010-07-01)

Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in cN0 Breast Cancer: Impact of HER2-Positive Status on Survival
by: Juan Alors-Ruiz, et al.
Published: (2024-04-01)

Intraoperative imprint cytology versus histological diagnosis for the detection of sentinel lymph nodes in breast cancer treated with neoadjuvant chemotherapy
by: Ronald Enrique Delgado-Bocanegra, et al.
Published: (2018-08-01)

P204 SPECT/CT lymphoscintigraphy can accurately localize the sentinel lymph nodes and the clipped node in breast cancer patients undergoing targeted axillary dissection after neoadjuvant chemotherapy
by: E. Dilege, et al.
Published: (2023-03-01)

Role of number of sentinel nodes in predicting non-sentinel node metastasis in breast cancer
by: Li-Feng Dong, et al.
Published: (2018-02-01)

Axillary lymph node dissection versus radiotherapy in breast cancer with positive sentinel nodes after neoadjuvant therapy (ADARNAT trial)
by: Amparo Garcia-Tejedor, et al.
Published: (2023-08-01)

The Oncologic Safety of Sentinel Lymph Node Biopsy in Patients with Node-Positive Breast Cancer with Complete Response to Neoadjuvant Chemotherapy: A Single-Center Experience
by: Ismail Can Tercan, et al.
Published: (2023-01-01)

A Propensity Score Matched Analysis of Superparamagnetic Iron Oxide versus Radioisotope Sentinel Node Biopsy in Breast Cancer Patients after Neoadjuvant Chemotherapy
by: Zuzanna Pelc, et al.
Published: (2022-01-01)

Feasibility of Sentinel Lymph Node Biopsy in Breast Cancer Patients with Axillary Conversion after Neoadjuvant Chemotherapy—A Single-Tertiary Centre Experience and Review of the Literature
by: Alexandra Maria Lazar, et al.
Published: (2023-09-01)

Feasibility and reliability of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer patients with positive axillary nodes at initial diagnosis: An up-to-date meta-analysis of 3,578 patients
by: Siyang Cao, et al.
Published: (2021-10-01)

P287 Overall survival after neoadjuvant chemotherapy depending on pathological response and tumoral phenotype
by: M. Ciaurriz Gortari, et al.
Published: (2023-03-01)

Ultrasound Accuracy in Detection of Metastatic Axillary Lymph Nodes in Breast Cancer after Neoadjuvant Chemotherapy
by: Majid Akrami, et al.
Published: (2023-01-01)

Questionnaire study of application about sentinel lymph node biopsy surgery in locally advanced breast cancer patients who received neoadjuvant chemotherapy
by: Eun-Gyeong Lee, et al.
Published: (2023-10-01)

The Number of Nodes Examined in the Sentinel Lymph Node Biopsy Dictates Melanoma Survival
by: Daniela Duarte Bateman, MD, et al.
Published: (2023-10-01)

P282 Survival outcomes after neoadjuvant chemotherapy according to the axillary status and tumor subtype
by: L. López-Marín, et al.
Published: (2023-03-01)

Utilization of neoadjuvant chemotherapy in high‐risk, node‐negative early breast cancer
by: Ipshita Prakash, et al.
Published: (2022-02-01)

Is Pathologic Axillary Staging Valid If Lymph Nodes Are Less than 10 with Axillary Lymph Node Dissection after Neoadjuvant Chemotherapy?
by: Hee Jun Choi, et al.
Published: (2022-11-01)

After neoadjuvant therapy, axillary sentinel lymph node frozen sections from breast cancer patients are accurately diagnosed using telepathology
by: Valarie McMurtry, et al.
Published: (2022-01-01)

The Prognostic Value of Lymph Node Involvement after Neoadjuvant Chemotherapy Is Different among Breast Cancer Subtypes
by: Lucie Laot, et al.
Published: (2021-01-01)

Laparoscopic left hepatectomy combined with regional lymph node dissection after neoadjuvant chemotherapy for intrahepatic cholangiocarcinoma
by: Jie Huang, et al.
Published: (2023-08-01)

Lymph Node Ratio (LNR): Predicting Prognosis after Neoadjuvant Chemotherapy (NAC) in Breast Cancer Patients
by: Atilla Soran, et al.
Published: (2019-10-01)

Is number of sentinel nodes enougth after neoadjuvant chemotherapy?

Similar Items

Similar Items